Annual report
3645.TEDINET S100P43U
Period2021-06-01 → 2022-05-31
Filed2022-08-31
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥3.7bn | 2021-06-01 → 2022-05-31 | Cons. | Net sales |
| Revenue | ¥2.9bn | 2020-06-01 → 2021-05-31 | Cons. | Net sales |
| Revenue | ¥2.6bn | 2019-06-01 → 2020-05-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.0bn | 2018-06-01 → 2019-05-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.5bn | 2017-06-01 → 2018-05-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥450m | 2021-06-01 → 2022-05-31 | Cons. | Operating income |
| Operating income | ¥331m | 2020-06-01 → 2021-05-31 | Cons. | Operating income |
| Ordinary income | ¥454m | 2021-06-01 → 2022-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥336m | 2020-06-01 → 2021-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥104m | 2019-06-01 → 2020-05-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥183m | 2018-06-01 → 2019-05-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥155m | 2017-06-01 → 2018-05-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥539m | 2021-06-01 → 2022-05-31 | Cons. | Income before income taxes |
| Profit before tax | ¥254m | 2020-06-01 → 2021-05-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥385m | 2021-06-01 → 2022-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥130m | 2020-06-01 → 2021-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥79m | 2019-06-01 → 2020-05-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥102m | 2018-06-01 → 2019-05-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥88m | 2017-06-01 → 2018-05-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥401m | 2021-06-01 → 2022-05-31 | Cons. | Profit loss |
| Net income | ¥138m | 2020-06-01 → 2021-05-31 | Cons. | Profit loss |
| Total assets | ¥3.2bn | at 2022-05-31 | Cons. | Assets |
| Total assets | ¥2.1bn | at 2021-05-31 | Cons. | Assets |
| Total assets | ¥1.7bn | at 2020-05-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥2.1bn | at 2019-05-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥1.9bn | at 2018-05-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.4bn | at 2022-05-31 | Cons. | Liabilities |
| Total liabilities | ¥847m | at 2021-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.7bn | at 2022-05-31 | Cons. | Net assets |
| Net assets / equity | ¥1.3bn | at 2021-05-31 | Cons. | Net assets |
| Net assets / equity | ¥1.0bn | at 2020-05-31d | Cons. | Net assets |
| Net assets / equity | ¥1.6bn | at 2019-05-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥1.6bn | at 2018-05-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.1bn | at 2022-05-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥869m | at 2021-05-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.1bn | at 2022-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥869m | at 2021-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥596m | at 2020-05-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.0bn | at 2019-05-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.2bn | at 2018-05-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥343m | 2021-06-01 → 2022-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥392m | 2020-06-01 → 2021-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥78m | 2019-06-01 → 2020-05-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥22m | 2018-06-01 → 2019-05-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥116m | 2017-06-01 → 2018-05-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥355m | 2021-06-01 → 2022-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥88m | 2020-06-01 → 2021-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥15m | 2019-06-01 → 2020-05-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥145m | 2018-06-01 → 2019-05-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥43m | 2017-06-01 → 2018-05-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥282m | 2021-06-01 → 2022-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥34m | 2020-06-01 → 2021-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥497m | 2019-06-01 → 2020-05-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥21m | 2018-06-01 → 2019-05-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥50m | 2017-06-01 → 2018-05-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥43.98 | 2021-06-01 → 2022-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥15.36 | 2020-06-01 → 2021-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥9.26 | 2019-06-01 → 2020-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥9.49 | 2018-06-01 → 2019-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥8.18 | 2017-06-01 → 2018-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥193.73 | at 2022-05-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥144.23 | at 2021-05-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥123.32 | at 2020-05-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥151.83 | at 2019-05-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥143.51 | at 2018-05-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 54.1% | at 2022-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 59.0% | at 2021-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.4% | at 2020-05-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 79.7% | at 2019-05-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 82.0% | at 2018-05-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 26.1% | 2021-06-01 → 2022-05-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.6% | 2020-06-01 → 2021-05-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.0% | 2019-06-01 → 2020-05-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.4% | 2018-06-01 → 2019-05-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.8% | 2017-06-01 → 2018-05-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 163 | at 2022-05-31 | Cons. | Number of employees |
| Employees | 113 | at 2021-05-31 | Cons. | Number of employees |
| Employees | 110 | at 2020-05-31d | Cons. | Number of employees |
| Employees | 102 | at 2019-05-31d | Cons. | Number of employees |
| Employees | 98 | at 2018-05-31d | Cons. | Number of employees |
| Revenue | ¥1.6bn | 2021-06-01 → 2022-05-31 | Standalone | Net sales |
| Revenue | ¥1.4bn | 2020-06-01 → 2021-05-31 | Standalone | Net sales |
| Revenue | ¥1.2bn | 2019-06-01 → 2020-05-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.3bn | 2018-06-01 → 2019-05-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.4bn | 2017-06-01 → 2018-05-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥365m | 2021-06-01 → 2022-05-31 | Standalone | Operating income |
| Operating income | ¥318m | 2020-06-01 → 2021-05-31 | Standalone | Operating income |
| Ordinary income | ¥352m | 2021-06-01 → 2022-05-31 | Standalone | Ordinary income |
| Ordinary income | ¥322m | 2020-06-01 → 2021-05-31 | Standalone | Ordinary income |
| Ordinary income | ¥97m | 2019-06-01 → 2020-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥237m | 2018-06-01 → 2019-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥194m | 2017-06-01 → 2018-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥351m | 2021-06-01 → 2022-05-31 | Standalone | Income before income taxes |
| Profit before tax | ¥240m | 2020-06-01 → 2021-05-31 | Standalone | Income before income taxes |
| Net income | ¥248m | 2021-06-01 → 2022-05-31 | Standalone | Profit loss |
| Net income | ¥137m | 2020-06-01 → 2021-05-31 | Standalone | Profit loss |
| Net income | ¥70m | 2019-06-01 → 2020-05-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥49m | 2018-06-01 → 2019-05-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥137m | 2017-06-01 → 2018-05-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥2.5bn | at 2022-05-31 | Standalone | Assets |
| Total assets | ¥1.8bn | at 2021-05-31 | Standalone | Assets |
| Total assets | ¥1.5bn | at 2020-05-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.9bn | at 2019-05-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥2.0bn | at 2018-05-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥929m | at 2022-05-31 | Standalone | Liabilities |
| Total liabilities | ¥551m | at 2021-05-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.6bn | at 2022-05-31 | Standalone | Net assets |
| Net assets / equity | ¥1.3bn | at 2021-05-31 | Standalone | Net assets |
| Net assets / equity | ¥1.0bn | at 2020-05-31d | Standalone | Net assets |
| Net assets / equity | ¥1.7bn | at 2019-05-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.6bn | at 2018-05-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥798m | at 2022-05-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥675m | at 2021-05-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥28.4 | 2021-06-01 → 2022-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥16.23 | 2020-06-01 → 2021-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥8.2 | 2019-06-01 → 2020-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥4.56 | 2018-06-01 → 2019-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥12.73 | 2017-06-01 → 2018-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥4 | 2021-06-01 → 2022-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥4 | 2020-06-01 → 2021-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥1.5 | 2019-06-01 → 2020-05-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥2 | 2018-06-01 → 2019-05-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥2 | 2017-06-01 → 2018-05-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥181.56 | at 2022-05-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥148.43 | at 2021-05-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥127.15 | at 2020-05-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥155.37 | at 2019-05-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥152 | at 2018-05-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 63.3% | at 2022-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 69.9% | at 2021-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.8% | at 2020-05-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 89.4% | at 2019-05-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 83.6% | at 2018-05-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 17.3% | 2021-06-01 → 2022-05-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.9% | 2020-06-01 → 2021-05-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.2% | 2019-06-01 → 2020-05-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 3.0% | 2018-06-01 → 2019-05-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.7% | 2017-06-01 → 2018-05-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 10,773,000 | at 2022-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,773,000 | at 2021-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,773,000 | at 2020-05-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,773,000 | at 2019-05-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,773,000 | at 2018-05-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 98 | at 2022-05-31 | Standalone | Number of employees |
| Employees | 89 | at 2021-05-31 | Standalone | Number of employees |
| Employees | 93 | at 2020-05-31d | Standalone | Number of employees |
| Employees | 79 | at 2019-05-31d | Standalone | Number of employees |
| Employees | 83 | at 2018-05-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 77
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-06-01 → 2022-05-31 | ¥4m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-06-01 → 2022-05-31 | ¥4m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-06-01 → 2022-05-31 | ¥4m |
| Mediaplatformreportable segment | depreciation | 2021-06-01 → 2022-05-31 | ¥2m |
| Mediaplatformreportable segment | employees | at 2022-05-31 | 24 pure |
| Mediaplatformreportable segment | revenue | 2021-06-01 → 2022-05-31 | ¥994m |
| Mediaplatformreportable segment | revenue external | 2021-06-01 → 2022-05-31 | ¥994m |
| Mediaplatformreportable segment | segment assets | at 2022-05-31 | ¥72m |
| Mediaplatformreportable segment | segment profit | 2021-06-01 → 2022-05-31 | ¥616m |
| Medical B To Breportable segment | depreciation | 2021-06-01 → 2022-05-31 | ¥441,000 |
| Medical B To Breportable segment | employees | at 2022-05-31 | 8 pure |
| Medical B To Breportable segment | revenue | 2021-06-01 → 2022-05-31 | ¥169m |
| Medical B To Breportable segment | revenue external | 2021-06-01 → 2022-05-31 | ¥169m |
| Medical B To Breportable segment | revenue intersegment | 2021-06-01 → 2022-05-31 | ¥17,000 |
| Medical B To Breportable segment | segment assets | at 2022-05-31 | ¥19m |
| Medical B To Breportable segment | segment profit | 2021-06-01 → 2022-05-31 | ¥58m |
| Medical Institution Management Supportreportable segment | capex | 2021-06-01 → 2022-05-31 | ¥2m |
| Medical Institution Management Supportreportable segment | depreciation | 2021-06-01 → 2022-05-31 | ¥10m |
| Medical Institution Management Supportreportable segment | employees | at 2022-05-31 | 108 pure |
| Medical Institution Management Supportreportable segment | revenue | 2021-06-01 → 2022-05-31 | ¥2.6bn |
| Medical Institution Management Supportreportable segment | revenue external | 2021-06-01 → 2022-05-31 | ¥2.6bn |
| Medical Institution Management Supportreportable segment | revenue intersegment | 2021-06-01 → 2022-05-31 | ¥888,000 |
| Medical Institution Management Supportreportable segment | segment assets | at 2022-05-31 | ¥2.3bn |
| Medical Institution Management Supportreportable segment | segment profit | 2021-06-01 → 2022-05-31 | ¥208m |
| —segment total | capex | 2021-06-01 → 2022-05-31 | ¥2m |
| —segment total | depreciation | 2021-06-01 → 2022-05-31 | ¥12m |
| —segment total | revenue | 2021-06-01 → 2022-05-31 | ¥3.7bn |
| —segment total | revenue external | 2021-06-01 → 2022-05-31 | ¥3.7bn |
| —segment total | revenue intersegment | 2021-06-01 → 2022-05-31 | ¥906,000 |
| —segment total | segment assets | at 2022-05-31 | ¥2.4bn |
| —segment total | segment profit | 2021-06-01 → 2022-05-31 | ¥882m |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-06-01 → 2022-05-31 | ¥2m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-06-01 → 2022-05-31 | ¥12m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-06-01 → 2022-05-31 | ¥3.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-06-01 → 2022-05-31 | ¥3.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-06-01 → 2022-05-31 | ¥906,000 |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-05-31 | ¥2.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-06-01 → 2022-05-31 | ¥886m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2020-06-01 → 2021-05-31 | ¥4m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2020-06-01 → 2021-05-31 | ¥4m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2020-06-01 → 2021-05-31 | ¥4m |
| Mediaplatformreportable segment | capex | 2020-06-01 → 2021-05-31 | ¥1m |
| Mediaplatformreportable segment | depreciation | 2020-06-01 → 2021-05-31 | ¥1m |
| Mediaplatformreportable segment | revenue | 2020-06-01 → 2021-05-31 | ¥891m |
| Mediaplatformreportable segment | revenue external | 2020-06-01 → 2021-05-31 | ¥891m |
| Mediaplatformreportable segment | segment assets | at 2021-05-31 | ¥127m |
| Mediaplatformreportable segment | segment profit | 2020-06-01 → 2021-05-31 | ¥590m |
| Medical B To Breportable segment | depreciation | 2020-06-01 → 2021-05-31 | ¥360,000 |
| Medical B To Breportable segment | revenue | 2020-06-01 → 2021-05-31 | ¥134m |
| Medical B To Breportable segment | revenue external | 2020-06-01 → 2021-05-31 | ¥134m |
| Medical B To Breportable segment | revenue intersegment | 2020-06-01 → 2021-05-31 | ¥413,000 |
| Medical B To Breportable segment | segment assets | at 2021-05-31 | ¥18m |
| Medical B To Breportable segment | segment profit | 2020-06-01 → 2021-05-31 | ¥59m |
| Medical Institution Management Supportreportable segment | capex | 2020-06-01 → 2021-05-31 | ¥4m |
| Medical Institution Management Supportreportable segment | depreciation | 2020-06-01 → 2021-05-31 | ¥8m |
| Medical Institution Management Supportreportable segment | revenue | 2020-06-01 → 2021-05-31 | ¥1.9bn |
| Medical Institution Management Supportreportable segment | revenue external | 2020-06-01 → 2021-05-31 | ¥1.9bn |
| Medical Institution Management Supportreportable segment | revenue intersegment | 2020-06-01 → 2021-05-31 | ¥998,000 |
| Medical Institution Management Supportreportable segment | segment assets | at 2021-05-31 | ¥946m |
| Medical Institution Management Supportreportable segment | segment profit | 2020-06-01 → 2021-05-31 | ¥83m |
| —segment total | capex | 2020-06-01 → 2021-05-31 | ¥6m |
| —segment total | depreciation | 2020-06-01 → 2021-05-31 | ¥9m |
| —segment total | revenue | 2020-06-01 → 2021-05-31 | ¥2.9bn |
| —segment total | revenue external | 2020-06-01 → 2021-05-31 | ¥2.9bn |
| —segment total | revenue intersegment | 2020-06-01 → 2021-05-31 | ¥1m |
| —segment total | segment assets | at 2021-05-31 | ¥1.1bn |
| —segment total | segment profit | 2020-06-01 → 2021-05-31 | ¥731m |
| Total Of Reportable Segments And Otherssegment total | capex | 2020-06-01 → 2021-05-31 | ¥6m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2020-06-01 → 2021-05-31 | ¥9m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-06-01 → 2021-05-31 | ¥2.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-06-01 → 2021-05-31 | ¥2.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2020-06-01 → 2021-05-31 | ¥1m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2021-05-31 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-06-01 → 2021-05-31 | ¥735m |
| Mediaplatformreportable segment | employees | at 2022-05-31 | 24 pure |
| Medical B To Breportable segment | employees | at 2022-05-31 | 8 pure |
| Medical Institution Management Supportreportable segment | employees | at 2022-05-31 | 43 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,367
| Item | Context | Value | Unit |
|---|---|---|---|
| Repayment of long term loans payable fin cf | CurrentYearDuration | -74585000 | JPY |
| Cash dividends paid fin cf | Prior1YearDuration | -6156000 | JPY |
| Cash dividends paid fin cf | CurrentYearDuration | -34227000 | JPY |
| Proceeds from share issuance to non controlling shareholders fin cf | Prior1YearDuration | － | JPY |
| Proceeds from share issuance to non controlling shareholders fin cf | CurrentYearDuration | 60000 | JPY |
| Other net fin cf | Prior1YearDuration | － | JPY |
| Other net fin cf | CurrentYearDuration | 986000 | JPY |
| Net cash provided by used in financing activities | Prior1YearDuration | -34032000 | JPY |
| Net cash provided by used in financing activities | CurrentYearDuration | 282234000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YearDuration | 2922000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYearDuration | -9546000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YearDuration | 272765000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYearDuration | 260127000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 595895000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 868661000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 868661000 | JPY |
| Cash and cash equivalents | CurrentYearInstant | 1128788000 | JPY |
| Number of consolidated subsidiaries | CurrentYearInstant | 8 | |
| Accumulated depreciation ppe by group | Prior1YearInstant | -167754000 | JPY |
| Accumulated depreciation ppe by group | CurrentYearInstant | -279788000 | JPY |
| Directors compensations sga | Prior1YearDuration | 118737000 | JPY |
| Directors compensations sga | CurrentYearDuration | 149109000 | JPY |
| Salaries and allowances sga | Prior1YearDuration | 251916000 | JPY |
| Salaries and allowances sga | CurrentYearDuration | 306585000 | JPY |
| Advertising expenses sga | Prior1YearDuration | 72229000 | JPY |
| Advertising expenses sga | CurrentYearDuration | 108643000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1YearDuration | 1842000 | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYearDuration | 10914000 | JPY |
| Research and development expenses included in general and administrative expenses and manufacturing cost for current period | Prior1YearDuration | 11940000 | JPY |
| Research and development expenses included in general and administrative expenses and manufacturing cost for current period | CurrentYearDuration | 8004000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E24982-000MediaplatformReportableSegmentsMember | 891266000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E24982-000MedicalInstitutionManagementSupportReportableSegmentsMember | 1875713000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E24982-000MedicalBToBReportableSegmentsMember | 133913000 | JPY |
| Revenues from external customers | Prior1YearDuration_ReportableSegmentsMember | 2900893000 | JPY |
| Revenues from external customers | Prior1YearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 3708000 | JPY |
| Revenues from external customers | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | 2904602000 | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E24982-000MediaplatformReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E24982-000MedicalInstitutionManagementSupportReportableSegmentsMember | 998000 | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E24982-000MedicalBToBReportableSegmentsMember | 413000 | JPY |
| Transactions with other segments | Prior1YearDuration_ReportableSegmentsMember | 1411000 | JPY |
| Transactions with other segments | Prior1YearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | 1411000 | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E24982-000MediaplatformReportableSegmentsMember | 891266000 | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E24982-000MedicalInstitutionManagementSupportReportableSegmentsMember | 1876712000 | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E24982-000MedicalBToBReportableSegmentsMember | 134327000 | JPY |
| Net sales | Prior1YearDuration_ReportableSegmentsMember | 2902305000 | JPY |
| Net sales | Prior1YearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 3708000 | JPY |
| Net sales | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | 2906013000 | JPY |
| Operating income | Prior1YearDuration_jpcrp030000-asr_E24982-000MediaplatformReportableSegmentsMember | 589878000 | JPY |
| Operating income | Prior1YearDuration_jpcrp030000-asr_E24982-000MedicalInstitutionManagementSupportReportableSegmentsMember | 82585000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |